LONDON: A study found that the ovarian reserve of women, previously infected with COVID-19, is not adversely affected and the chances of fertility treatment remains unchanged. The study was led by the researchers at IVI Madrid, a fertility clinic in Spain, and it assures those who are planning fertility treatment. The findings were published in ESHRE’s 37th Annual Meeting from June 26 to July 1.
The researchers analysed the hormone levels in 46 women undergoing In-Vitro Fertilisation (IVF) in Spain including the measurements of anti-Mullerian hormone (AMH). AMH has become a widely used measurement parameter in fertility clinics and predicts how patients may respond to ovarian stimulation. The study found no variation in AMH measurement among the normal responders and the COVID-19 infection is unlikely to affect the ovarian reserve.
The study mentioned that there was variation in the level of AMH as a marker of ovarian reserve but the change was due to the patient response to ovarian stimulation and not due to previous infection.